PharmAthene Company Profile (NYSE:PIP)

About PharmAthene

PharmAthene logoPharmathene, Inc. (Pharmathene) is a biodefense company. The Company is focused on the development of medical counter measures against biological and chemical threats. The Company is involved in the development of two next generation anthrax vaccines. The Company's anthrax vaccines use recombinant protective antigen (rPA) manufacturing processes. The Company's product portfolio includes recombinant butyrylcholinesterase (rBChE) bioscavenger, which is used in prevention and treatment of nerve agent poisoning. The Company has developed a recombinant form of human butyrylcholinesterase for pre- and post-exposure therapy to patients with nerve agent attacks. Its rBChE bioscavenger acts with mechanism, which includes reversal of the acute toxicity associated with organophosphate poisoning agents used in chemical warfare (cholinergic crisis). Its development program also includes Valortim for monoclonal human antibody treatment.

Industry, Sector and Symbol:
  • Sector: Finance
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: PIP
  • CUSIP:
Key Metrics:
  • Previous Close: $1.03
  • 50 Day Moving Average: $2.51
  • 200 Day Moving Average: $2.78
  • 52-Week Range: $0.47 - $3.50
  • Trailing P/E Ratio: 0.55
  • Foreward P/E Ratio: -13.86
  • P/E Growth: 0.00
  • Market Cap: $64.73M
  • Outstanding Shares: 66,728,000
Additional Links:
Companies Related to PharmAthene:

Analyst Ratings

Consensus Ratings for PharmAthene (NYSE:PIP) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for PharmAthene (NYSE:PIP)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for PharmAthene (NYSE:PIP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/9/2017        
3/10/2015($0.03)($0.04)ViewN/AView Earnings Details
11/10/2014($0.03)($0.07)ViewN/AView Earnings Details
8/4/2014($0.06)($0.01)ViewN/AView Earnings Details
5/8/2014($0.06)($0.04)ViewN/AView Earnings Details
3/11/2014Q4($0.05)($0.08)ViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for PharmAthene (NYSE:PIP)
Current Year EPS Consensus Estimate: $-0.10 EPS
Next Year EPS Consensus Estimate: $-0.07 EPS

Dividends

Current Dividend Information for PharmAthene (NYSE:PIP)
Annual Dividend:$0.00
Dividend Yield:0.00%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:0.00% (Based on Current Year Consensus EPS Estimate)
0.00% (Based on Next Year Consensus EPS Estimate)

Dividend History for PharmAthene (NYSE:PIP)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
11/21/2016special$2.912/6/20171/24/20162/3/2017
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for PharmAthene (NYSE:PIP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/9/2016Prescott Group Capital ManagemMajor ShareholderSell1,354,632$3.26$4,416,100.32View SEC Filing  
4/13/2016Eric I RichmanDirectorSell329,354$2.20$724,578.80View SEC Filing  
4/8/2016Eric I RichmanDirectorSell11,767$2.20$25,887.40View SEC Filing  
3/19/2015Peter Steven StDirectorBuy25,000$1.65$41,250.00View SEC Filing  
1/7/2015Linda L ChangCFOSell29,600$2.10$62,160.00View SEC Filing  
9/22/2014Prescott Group Capital ManagemMajor ShareholderBuy15,000$1.55$23,250.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for PharmAthene (NYSE:PIP)
DateHeadline
News IconStock On the Run: PharmAthene, Inc. (NYSEMKT:PIP) - HugoPress (NYSE:PIP)
hugopress.com - February 23 at 9:00 AM
News IconMarket Movers – TCF Financial Corporation (NYSE:TCB), PharmAthene, Inc. (NYSEMKT:PIP) - Wall Street Times (press release) (NYSE:PIP)
www.wallstreetnews24.com - February 23 at 9:00 AM
News IconStock Price of PharmAthene, Inc (PIP) Decreases -7.96% - Energy Index (NYSE:PIP)
www.energyindexwatch.com - February 22 at 7:21 PM
News IconPharmAthene, Inc. (:PIP) Insider Selling Update - Winfield Review (NYSE:PIP)
winfieldreview.com - February 22 at 7:21 PM
News IconPharmAthene, Inc. (PIP) added to 34 new portfolios - Post Analyst (NYSE:PIP)
postanalyst.com - February 22 at 7:21 PM
News IconSell-Side Analyst's Predictions: Sabre Corporation (SABR), PharmAthene, Inc. (PIP) - The USA Commerce (NYSE:PIP)
theusacommerce.com - February 22 at 7:21 PM
News IconThe Case for and Against PharmAthene, Inc. (PIP) - StockNewsJournal (NYSE:PIP)
www.stocknewsjournal.com - February 22 at 7:21 PM
News IconPharmAthene, Inc. (PIP) Recent Ownership Changes - Post Analyst (NYSE:PIP)
postanalyst.com - February 20 at 6:28 PM
News IconThe Must-Know Technicals As They Stand For PharmAthene, Inc. (PIP) - NY Stock News (NYSE:PIP)
nystocknews.com - February 20 at 6:28 PM
News IconLet's Get Complex With PharmAthene, Inc. (PIP) - Post Analyst (NYSE:PIP)
postanalyst.com - February 20 at 9:27 AM
finance.yahoo.com logoPepsico CFO: We have terrific momentum (NYSE:PIP)
finance.yahoo.com - February 16 at 6:51 PM
finance.yahoo.com logoPepsico CFO: Great business in Mexico (NYSE:PIP)
finance.yahoo.com - February 16 at 6:51 PM
News IconZoetis Inc. (NYSE:ZTS), PharmAthene, Inc. (NYSEMKT:PIP) (NYSE:PIP)
eleganthomesinla.com - February 15 at 4:29 AM
News IconPharmAthene, Inc. (:PIP) Sees The Needle Move on Volume - Winfield Review (NYSE:PIP)
winfieldreview.com - February 14 at 4:14 AM
News IconStock on Trader's Radar: PharmAthene, Inc. (NYSEMKT:PIP) – Post ... - Post Registrar (NYSE:PIP)
postregistrar.com - February 14 at 4:14 AM
istreetwire.com logoMomentum Stocks: Hanesbrands Inc. (HBI), Twilio Inc. (TWLO), PharmAthene, Inc. (PIP) (NYSE:PIP)
istreetwire.com - February 10 at 8:15 PM
istreetwire.com logoTraders Watch list: PharmAthene, Inc. (PIP), Galena Biopharma, Inc. (GALE), Cobalt International Energy, Inc. (CIE) - iStreetWire (NYSE:PIP)
istreetwire.com - February 10 at 2:30 AM
News IconLarge Buying Action and Inflow of Money Witnessed in PharmAthene, Inc - Highland Mirror (NYSE:PIP)
www.highlandmirror.com - February 8 at 8:12 PM
thestreet.com logoBiotech Premarket Movers: PharmAthene, Earth Science Tech, Pulmatrix (NYSE:PIP)
www.thestreet.com - February 7 at 9:03 PM
finance.yahoo.com logoAltimmune to Present at the BIO CEO & Investor Conference (NYSE:PIP)
finance.yahoo.com - February 6 at 9:06 AM
streetinsider.com logoForm 425 PHARMATHENE, INC Filed by: PHARMATHENE, INC (NYSE:PIP)
www.streetinsider.com - February 1 at 9:41 PM
wsj.com logo[$$] Gormley's Take: As IPO Market Tightens, Biotechs Find Another Route to Public Listing (NYSE:PIP)
www.wsj.com - February 1 at 9:41 PM
News IconTrading Scope: Checking on Shares of PharmAthene, Inc. (AMEX:PIP) - The Tribune (NYSE:PIP)
lakecitytribune.com - January 31 at 12:57 AM
News IconVolatility Numbers in View for PharmAthene, Inc. (AMEX:PIP) - Gilbert Daily (NYSE:PIP)
gilbertdaily.com - January 30 at 8:26 AM
News IconTicker Tracker: Looking at PharmAthene Inc. (PIP) - Rives Journal (NYSE:PIP)
rivesjournal.com - January 28 at 7:22 PM
4-traders.com logoPharmAthene : and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious Diseases (NYSE:PIP)
www.4-traders.com - January 27 at 12:52 AM
investopedia.com logoPharmAthene and Altimmune to Merge in All-Stock Deal (NYSE:PIP)
www.investopedia.com - January 23 at 7:33 PM
bizjournals.com logoTwo of region's anthrax-fighting companies announce merger (NYSE:PIP)
us.rd.yahoo.com - January 20 at 8:05 PM
capitalcube.com logoETFs with exposure to PharmAthene, Inc. : January 20, 2017 (NYSE:PIP)
www.capitalcube.com - January 20 at 8:05 PM
streetinsider.com logoPharmAthene (PIP), Altimmune to Merge in All-Stock Transaction - StreetInsider.com (NYSE:PIP)
www.streetinsider.com - January 20 at 1:18 AM
finance.yahoo.com logoPharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious Diseases (NYSE:PIP)
finance.yahoo.com - January 20 at 1:18 AM
finance.yahoo.com logo6:32 am PharmAthene and privately-held Altimmune announce merger in an all-stock transaction (NYSE:PIP)
finance.yahoo.com - January 20 at 1:17 AM
biz.yahoo.com logoPHARMATHENE, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Off (NYSE:PIP)
biz.yahoo.com - January 20 at 1:17 AM
feeds.benzinga.com logoMid-Afternoon Market Update: Dow Slides Over 100 Points; CSX Shares Spike Higher (NYSE:PIP)
feeds.benzinga.com - January 19 at 4:05 PM
News IconTop Rated Stock With Earnings Growth & Implied Upside: PharmAthene, Inc. (:PIP) - Prospect Journal (NYSE:PIP)
prospectjournal.com - January 16 at 7:44 PM
wallstrt24.com logoStocks Buzz Hormel Foods Corp (NYSE:HRL), PharmAthene, Inc. (NYSEMKT:PIP) - Wall Street 24 (NYSE:PIP)
wallstrt24.com - January 16 at 11:01 AM
News IconMerrimack Pharmaceuticals, Inc. (NASDAQ:MACK) , PharmAthene, Inc (NYSEMKT:PIP) - MMA Ring Report (NYSE:PIP)
mmaringreport.com - January 12 at 5:54 AM
News IconPharmAthene, Inc. (NYSEMKT:PIP) hit its 52 Week high of $3.45 on Jan 10, 2017 - The Newburgh Press (NYSE:PIP)
newburghpress.com - January 12 at 5:54 AM
News IconCan This Stock Gain Traction: PharmAthene, Inc. (:PIP) - Prospect Journal (NYSE:PIP)
prospectjournal.com - January 10 at 8:10 AM
News IconPharmAthene Inc PIP Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NYSE:PIP)
www.bioportfolio.com - January 10 at 12:57 AM
capitalcube.com logoETFs with exposure to PharmAthene, Inc. : January 9, 2017 (NYSE:PIP)
www.capitalcube.com - January 9 at 7:55 PM
News IconMylan N.V. (NASDAQ:MYL), PharmAthene, Inc. (NYSE:PIP) (NYSE:PIP)
diariocatolico.net - January 6 at 12:02 AM
News IconSteady Activities: PharmAthene, Inc. (NYSEMKT:PIP), Ocwen Financial Corp. (NYSE:OCN) - The Newburgh Press (NYSE:PIP)
newburghpress.com - January 5 at 1:07 AM
News IconGrowth Story Unfolding for PharmAthene, Inc. (:PIP) - Prospect Journal (NYSE:PIP)
prospectjournal.com - January 3 at 10:14 AM
News IconFortress Biotech, Inc. (NASDAQ:FBIO) , PharmAthene, Inc (NYSEMKT:PIP) - Henderson State University News Blog (NYSE:PIP)
hsunews.com - December 31 at 8:30 AM
capitalcube.com logoETFs with exposure to PharmAthene, Inc. : December 29, 2016 (NYSE:PIP)
www.capitalcube.com - December 29 at 7:14 PM
News IconMeasuring the Levels on Shares of PharmAthene Inc. (PIP) - Yankee Analysts (NYSE:PIP)
yankeeanalysts.com - December 21 at 9:32 AM
News IconInvestors are Looking at Levels for PharmAthene Inc. (PIP) - Yankee Analysts (NYSE:PIP)
yankeeanalysts.com - December 20 at 1:46 PM
News IconFollowing the Numbers for PharmAthene, Inc. (AMEX:PIP) - Liberty News (NYSE:PIP)
libertynewsrecord.com - December 20 at 1:46 PM
News IconInvestor Update: Checking on Shares of PharmAthene, Inc. (AMEX:PIP) - Liberty News (NYSE:PIP)
libertynewsrecord.com - December 19 at 8:25 AM

Social

What is PharmAthene's stock symbol?

PharmAthene trades on the New York Stock Exchange (NYSE) under the ticker symbol "PIP."

How often does PharmAthene pay dividends? What is the dividend yield for PharmAthene?

PharmAthene declared a special dividend on Monday, November 21st. Shareholders of record on Sunday, January 24th will be given a dividend of $2.91 per share on Friday, February 3rd. The ex-dividend date of this dividend is Monday, February 6th.

When will PharmAthene announce their earnings?

PharmAthene is scheduled to release their next quarterly earnings announcement on Thursday, March, 9th 2017.

How do I buy PharmAthene stock?

Shares of PharmAthene can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of PharmAthene stock cost?

One share of PharmAthene stock can currently be purchased for approximately $0.97.

PharmAthene (NYSE:PIP) Chart for Thursday, February, 23, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for PharmAthene (NYSE:PIP)

Earnings History Chart

Earnings by Quarter for PharmAthene (NYSE:PIP)

Dividend History Chart

Dividend Payments by Quarter for PharmAthene (NYSE:PIP)

Last Updated on 2/23/2017 by MarketBeat.com Staff